Finance

Beta
Lists
300765:SHE
CSPC Innovation Pharmaceutical Co Ltd
CN¥25.66
+0.39%
(+0.10) 1D
Jun 3, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300765...
Open
CN¥25.49
High
CN¥25.97
Low
CN¥25.07
Mkt. cap
35.90B
Avg. vol.
10.70M
Volume
9.85M
52-wk high
CN¥63.31
52-wk low
CN¥25.01
EPS
-CN¥0.22
Shares outstanding
1.40B
No. of employees
2K
Open
CN¥25.49
High
CN¥25.97
Low
CN¥25.07
Mkt. cap
35.90B
Avg. vol.
10.70M
Volume
9.85M
52-wk high
CN¥63.31
52-wk low
CN¥25.01
EPS
-CN¥0.22
Shares outstanding
1.40B
No. of employees
2K
News stories
From sources across the web
About CSPC Innovation Pharmaceutical Co Ltd
CEO-
Employees2.37K
FoundedApr 5, 2006
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
577.59M
543.46M
564.67M
664.65M
Cost of goods sold
366.69M
310.62M
376.85M
391.17M
Cost of revenue
366.69M
310.62M
376.85M
391.17M
Research and development expenses
214.90M
228.06M
352.58M
273.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
80.68M
100.83M
106.67M
100.10M
Operating expense
251.95M
397.25M
465.62M
387.35M
Total operating expenses
618.64M
707.88M
842.47M
778.51M
Operating income
-41.05M
-164.42M
-277.80M
-113.87M
Other non operating income
-14.31M
14.89M
-14.91M
-11.82M
EBT including unusual items
-27.53M
-109.92M
-285.97M
-119.61M
EBT excluding unusual items
-30.76M
-171.04M
-287.26M
-135.78M
Income tax expense
16.91M
13.53M
13.12M
10.26M
Effective tax rate
-61.42%
-12.31%
-4.59%
-8.58%
Other operating expenses
-49.97M
69.04M
6.95M
8.45M
Net income
24.16M
-21.30M
-217.08M
-93.85M
Net profit margin
4.18%
-3.92%
-38.44%
-14.12%
Earnings per share
-
-
-
-
Interest and investment income
7.64M
5.56M
-
4.05M
Interest expense
-3.77M
-6.35M
-13.11M
-14.13M
Net interest expenses
3.87M
-780.83K
-13.11M
-10.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.98M
-110.35M
-222.26M
-58.33M
Gain or loss from assets sale
-1.79M
1.79M
-2.78M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more